Following a Successful FDA Inspection, KBI Biopharma Extends and Expands Commercial Contract with Leading Global Pharmaceutical Company

Contributed by: Business Wire

Logo

Tags

Biotechnology

FDA

Pharmaceutical

Health

More Like This

KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions

Peter Carbone, KBI Biopharma Chief Quality Officer (Photo: Business Wire)

KBI Biopharma Strengthens Quality and Regulatory Affairs Expertise with Appointment of Chief Quality Officer

PR Newswire associated0

GBI Secures Commercial Manufacturing Contract, Solidifying Leadership in Radiopharmaceutical Manufacturing

JB Agnus, Chief Business Officer, KBI Biopharma, Inc. (Photo: Business Wire)

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

PR Newswire associated0

GBI Biomanufacturing Expands Capabilities with Automated Aseptic Fill-Finish for Drug Products

PR Newswire associated0

Ajinomoto Bio-Pharma Services Garners Six 'CDMO Leadership Awards,' Further Establishing Its Industry Excellence

PR Newswire associated0

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

Boston BioProducts Strengthens Leadership Team, Setting New Standards in Reagent Manufacturing and Quality